Israeli Legislation.com

Umbilical Cord Blood (Private Umbilical Cord Blood Bank) Regulations, 5772-2012

תקנות דם טבורי (בנק דם טבורי פרטי), תשע"ב-2012

Published: 2012-05-09Consolidated Hebrew text as of 2026-01-18 · Last amended 2024-06-16
Premium
Unofficial English translation — for reference only. It may contain errors or omissions and cannot be relied on as a legal text. Only the Hebrew text published in Reshumot is legally binding.More

This English text was translated from the official Hebrew using a range of translation tools, and it undergoes ongoing checks and updates. It is not a certified translation.

Despite these checks, it may contain errors, omissions, or imprecise renderings of legal terminology and cross-references, and it may not yet reflect the latest amendments. It cannot be relied upon as a legal text.

The Hebrew text as published in Reshumot (ספר החוקים) and on the Knesset website is the sole authoritative and legally binding version. In any discrepancy, the Hebrew text prevails.

This translation is provided for informational purposes only and does not constitute legal advice. For use in legal proceedings, request a certified Expert Legal Opinion.

By virtue of my authority under Sections 4(b), 6(f) and 14(a) of the Umbilical Cord Blood Law, 5767-2007 (hereinafter – the Law), and the authority under Sections 3(b), 5(a) and (c) and 6(b) of the Law, which I have assumed pursuant to Section 34 of Basic Law: The Government, and with the approval of the Labour, Welfare and Health Committee of the Knesset pursuant to Section 21a(a) of Basic Law: The Knesset and Section 2(b) of the Penal Law, 5737-1977, I hereby make these Regulations:

Chapter I: Interpretation

Definitions§

1.

In these Regulations –

"umbilical cord blood collector" – a person who has successfully completed designated training for the collection of umbilical cord blood as referred to in regulation 12;

"surrogate mother", "intended parents" – as defined in the Embryo Carrying Agreements Law (Approval of Agreement and Status of the Newborn), 5756-1996 (hereinafter – the Embryo Carrying Agreements Law);

"private bank" – a private umbilical cord blood bank;

"minimum public requirements" – the minimum requirements for the freezing and preservation of umbilical cord blood that are accepted at that time for the purpose of stem cell transplantation, pursuant to the instructions set by the Director under regulation 12 of the Public Umbilical Cord Blood Bank Regulations;

"client" – the mother giving birth, or a guardian of the newborn or of the mother giving birth who has ordered the collection of umbilical cord blood from a private bank;

"laboratory" or "medical laboratory" – as defined in the Public Health (Medical Laboratories) Regulations, 5737-1977;

"transaction" – an agreement between a private umbilical cord blood bank and a client, for the collection, processing and storage of umbilical cord blood in a private umbilical cord blood bank;

"Public Umbilical Cord Blood Bank Regulations" – the Umbilical Cord Blood (Public Umbilical Cord Blood Bank) Regulations, 5772-2012.

Chapter II: Informed Consent and Collection of the Unit

Disclosure of Information for the Purpose of Obtaining Informed Consent§

2.
(a)For the purpose of obtaining informed consent to the collection of umbilical cord blood and its processing, the mother giving birth shall be provided, in a language intelligible to her, with the information required by her, in writing and orally, in a reasonable manner, in order to decide whether to consent to the collection, processing, deposit and preservation of umbilical cord blood in a private bank, including information concerning –
(1)the purpose of collecting and preserving umbilical cord blood and the possible uses thereof as known at the time of collection;
(2)the process of collecting, testing – including genetic tests to be performed thereon – freezing and preserving the umbilical cord blood;
(3)the advantages, risks and limitations of collecting and preserving umbilical cord blood, including ethical aspects of the process;
(4)the possibilities for using the umbilical cord blood preserved in a private bank, and in particular that the umbilical cord blood unit will be preserved for the benefit of autologous transplantation or for the benefit of transplantation, in accordance with the instructions of the person after whose birth the umbilical cord blood was collected, or in accordance with the instructions of that person's guardian, only, and that it will not be possible to use it for any other purpose;
(5)the need to obtain medical information concerning the mother giving birth and the newborn and to take blood samples from the mother giving birth for the purpose of conducting tests and for preservation, and the reasons therefor;
(6)the need to keep information concerning the unit and the results of the tests conducted thereon, in an identifiable manner, and the manner in which the information will be kept while ensuring the rights of the newborn and the newborn's family members to medical confidentiality;
(7)the possibility that a umbilical cord blood unit may be found unsuitable for preservation, the conditions and criteria set by the private bank therefor, the consequences of finding the unit unsuitable for preservation as aforesaid and the circumstances in which the destruction of a unit that was collected or preserved will be permitted, pursuant to instructions to be set by the Director;
(8)the minimum requirements for freezing and preserving the unit in that private bank, and the minimum number of nucleated cells in a umbilical cord blood unit intended for freezing and preservation as set by the private bank pursuant to regulation 10, alongside the minimum public requirements as in force at that time;
(9)the impossibility of using the umbilical cord blood unit if the newborn is diagnosed in the future as suffering from certain diseases that shall be specified;
(10)a list of hospitals with which the private bank has an agreement enabling the collection of umbilical cord blood from mothers giving birth.
(b)The information shall be provided as early as possible and in a timely manner, in the circumstances of the matter, and also by means of an information leaflet that shall include the information in sub-regulation (a), in the form approved by the Director.
(c)Consent to the testing of the collected unit, the extraction of stem cells contained therein, its freezing and its preservation shall also be obtained from the father of the newborn, to the extent that he is known, and to the extent that there is a reasonable possibility of identifying, locating or ascertaining his opinion, in a timely manner; if the mother giving birth refused to provide the details of the father of the newborn – he shall be regarded, for this purpose, as a person who is unknown or in respect of whom there is no reasonable possibility of identifying, locating or ascertaining his opinion.

Consent Form§

3.
(a)The consent of the mother giving birth shall be given in writing, on a form containing the information in regulation 2(a), in the form approved by the Director (hereinafter – consent form), after she has received information from one of the following:
(1)a physician, nurse, midwife or umbilical cord blood collector;
(2)a licensed professional pursuant to legislation, in the field of health, or a holder of an academic degree in life sciences or medical sciences, who has undergone training approved by the Director for this purpose as referred to in regulation 13.
(b)A physician or midwife accompanying a birth shall permit the collection of umbilical cord blood from a mother giving birth only if they have verified the existence of a consent form signed by her.
(c)A consent form shall be signed in at least three copies, by the mother giving birth and by the person who provided her with the information; one copy shall be given to the mother giving birth, a second copy shall be kept in the medical file of the mother giving birth at the hospital, and a third copy shall be kept at the private bank.

Consent in Surrogacy§

4.

Informed consent to the act of collecting the umbilical cord blood shall be given by the mother giving birth, even if she is a surrogate mother; however, the intended parents shall instruct what is to be done with the collected unit; consent as aforesaid shall be given as early as possible in a timely manner, and the possibility of collecting umbilical cord blood at birth shall be stipulated in the embryo-carrying agreement, as defined in the Embryo Carrying Agreements Law.

Examination of the Mother Giving Birth§

5.
(a)A mother giving birth who has requested and consented to the collection of umbilical cord blood shall be tested for the presence of infectious disease agents, including the AIDS virus (HIV), in accordance with the Director's guidelines concerning the testing of blood units for infectious disease agents; the prior consent of the mother giving birth to the performance of the said tests shall be a condition for the collection of umbilical cord blood; the samples for the purpose of performing the tests shall be taken from the mother giving birth within a period of 30 days before the birth or during it.
(b)If umbilical cord blood was collected for a private bank and blood samples were not taken from the mother giving birth as referred to in sub-regulation (a), or were taken but the tests were not performed thereon, the private bank shall keep the unit separately from units that were tested and found to be in order, shall mark it as a unit that may be infected with an infectious disease, shall notify the client thereof and shall act in accordance with the client's instructions.

The Unit Collection Process§

6.
(a)The process of collecting a umbilical cord blood unit shall be carried out in a manner that protects the mother giving birth and the newborn and that shall have no effect on the course of the pregnancy, the birth process or the treatment of the mother giving birth and the newborn.
(b)No procedures shall be performed on the mother giving birth during the pregnancy and during the birth process, the sole purpose of which is to increase the volume of cells or their number in the umbilical cord blood unit to be collected.
(c)A umbilical cord blood unit shall be collected by an umbilical cord blood collector only, in a manner that ensures the quality and sterility of the unit and its suitability for freezing and preservation, pursuant to instructions to be set by the Director.

Chapter III: Requirements and Conditions for a Permit to Establish and Operate a Private Bank

Requirements and Conditions for Obtaining a Permit§

7.
(a)The Director shall not grant a permit for the establishment or operation of a private bank in Israel except to a person who is a permanent resident of Israel, or a corporation registered in Israel.
(b)An application for a permit for the establishment or operation of a private bank shall be submitted to the Director on the form in the Schedule, and the following shall be attached thereto –
(1)a detailed curriculum vitae of the person intended to serve as the medical director of the private bank, as well as certificates and documents for the verification of his or her education and experience;
(2)if the applicant is a corporation – the incorporation documents and the certificate of registration in the register maintained in Israel pursuant to any law, as well as details of all interested parties and managers of the corporation; in this paragraph, "interested party" – as defined in the Companies Law, 5759-1999;
(3)the consent of the applicant to the clarification of information concerning him or her in the criminal register, and in the case of a corporation – the consent of the controlling shareholders of the corporation to the clarification of information as aforesaid;
(4)any agreement made by the applicant with an appropriate medical laboratory, or a licence to manage an appropriate medical laboratory, in relation to the activities of the private bank;
(5)any agreement made by the applicant with a hospital that, under the terms of its registration, has a maternity ward, in relation to the collection of umbilical cord blood;
(6)any other agreement made by the applicant with a party involved in the work processes of the private bank, in relation to its activities;
(7)a sample of each information leaflet, consent form, waiver, deposit form and any contract with clients or other document intended to be delivered to clients, intended for use by the private bank;
(8)all bank procedures as referred to in these Regulations;
(9)full and clear information concerning the conditions for the cancellation of a transaction and the return of clients' funds for an unsuitable unit as referred to in regulation 16;
(10)a business licence granted to the private bank pursuant to the Business Licensing Law, 5728-1968, to the extent that it is required to have one.
(c)The Director may require the applicant to provide additional documents and information as the Director sees fit for the purpose of proving that the applicant meets the requirements of the law, the Regulations and the procedures.
(d)An agreement, a sample of any information leaflet or procedures submitted to the Director pursuant to sub-regulation (b), as well as additional documents and information submitted to the Director pursuant to sub-regulation (c), shall not contain commercial or financial information.
(e)A private bank that transfers, or intends to transfer, umbilical cord blood units collected from newborns in Israel, or part thereof, for storage outside Israel, shall state this prominently in the permit application, shall state in a prominent manner in every publication of the bank that the storage is or may be carried out outside Israel at a site not supervised by the Ministry of Health, and shall provide this information in writing to every client prior to obtaining informed consent to the collection.

Granting of a Permit and Its Renewal§

8.
(a)The Director shall not grant a permit for the establishment and operation of a private bank unless the Director is satisfied that the applicant has submitted all the information required pursuant to regulation 7 and meets all the requirements detailed in regulation 9, all while maintaining quality and safety in the processes of client recruitment, umbilical cord blood collection, performance of tests, processing, preservation, storage and supply of umbilical cord blood, including with respect to materials, equipment and medical devices required for the operation of the private bank.
(b)A permit shall be granted for a period of up to five years at a time, and shall be renewed only if the Director is satisfied that the applicant continues to meet all the requirements for the grant of a permit.
(c)A permit granted by the Director shall be renewed at the end of the period for an identical additional period, unless the Director has ordered that it not be renewed, provided that the Director has notified the permit holder of the intention not to renew it at least 60 days before the end of the permit period, and has given the permit holder an opportunity to present arguments on the matter and to rectify the deficiencies on account of which the Director is considering not renewing the permit as aforesaid.
(d)The Director shall not grant a permit unless the Director is satisfied that the applicant has sufficient financial stability, and the Director may require that securities be presented to clients to guarantee the fulfilment of the applicant's obligations towards the applicant's clients.

Professional Requirements for a Private Bank§

9.

A private bank (hereinafter – bank) shall be managed and operated in accordance with the following rules and in accordance with the Director's instructions concerning the management of medical laboratories, management of blood banks, quality assurance and information security:

(1)with respect to management, personnel and work procedures –
(a)the bank shall have a medical director who is a licensed physician with appropriate experience, and who shall be responsible for all professional and medical activity in the bank; nothing in this paragraph shall prevent the appointment of an additional director who is not a physician, for matters that are not medical;
(b)the bank is operated at all times by skilled professionals with training appropriate to their role or to the type of activity they perform in the bank;
(c)the bank has a position holder responsible for quality assurance, who is not the bank's director;
(d)the bank has a documented organisational structure that clearly defines the persons bearing responsibility and their areas of responsibility, the lines of authority and reporting obligations;
(e)the bank has documented and clear internal work procedures adapted to the type of activity performed in it;
(f)the bank has an efficient system for the recording and documentation of all activity performed in it;
(g)the bank has a system for keeping all significant information, including work procedures and records, for the period of time required pursuant to any law and pursuant to the procedures;
(2)with respect to structure, equipment and materials –
(a)the bank operates in a dedicated building and installations adapted to the bank's activities;
(b)umbilical cord blood units are kept in fixed, defined and controlled conditions that will ensure the preservation of the cells' properties;
(c)umbilical cord blood units in quarantine, released units and rejected units as defined in the procedures are kept in separate storage installations or in the same storage installation provided that appropriate separation measures have been taken, in a manner that prevents the mixing of units or their contamination, including cross-contamination;
(d)the bank holds at all times, in a controlled and documented manner, equipment, materials and reagents appropriate for their purpose, meeting all legal requirements or official standards existing in relation thereto, and maintains them in accordance with the manufacturer's instructions or other appropriate instructions, all while minimising possible risks;
(e)the processing of umbilical cord blood cells is carried out in appropriate environmental and ventilation conditions and in accordance with written work procedures, in a manner that minimises the possibility of contamination, including cross-contamination;
(f)the umbilical cord blood units are kept for at least the period guaranteed to clients in the agreement;
(3)with respect to quality and safety assurance –
(a)the bank operates a quality management system, all of whose activities are defined in procedures and documented;
(b)the bank has precautionary measures for the identification and minimisation of risks involved in the use of biological and chemical materials, while maintaining quality and safety adapted to the purpose of umbilical cord blood, including guidelines for the handling of a umbilical cord blood unit collected outside Israel and brought for preservation in a private bank in Israel;
(c)the medical director of the bank operates a system for close supervision to ensure that the quality and safety requirements necessary for the release of umbilical cord blood units for transplantation purposes are met in the umbilical cord blood units in the bank; the supervision system shall be defined in written procedures and all its activities shall be documented;
(d)the bank has installed an identification and tracking system that distinguishes between umbilical cord blood units intended for preservation, release, quarantine or rejection, all at each stage of the unit processing procedure;
(e)the medical director of the bank has defined the processes that are critical to the processing of the umbilical cord blood units, and in respect thereof there are detailed and validated work procedures, including rigorous documentation and quality control;
(f)the bank has a unit inventory control system that will prevent the release and supply of umbilical cord blood units that are not suitable for transplantation or for another purpose assigned to them;
(g)the bank operates in accordance with written and clear procedures for the packaging, labelling and transportation of umbilical cord blood units while ensuring the quality and safety of the units, and in particular for the certain labelling and identification of units received by the bank and released from it;
(h)the medical director of the bank maintains an efficient and documented system for the collection of information concerning the mother giving birth and the donor newborn, and for reporting to the bank on abnormal phenomena discovered in the mother giving birth, in the newborn or in the recipient, and on abnormal events during the processing of the umbilical cord blood units, which may affect the quality and safety of the units;
(i)any agreement between the bank and a laboratory, hospital or other party participating in the bank's work processes shall include detailed terms for regulating the relationship and the responsibilities between the parties, including binding work procedures for ensuring quality and safety, which shall include at least all of the following:
(1)authorisation of workers and their training, including periodic refresher training;
(2)maintaining the confidentiality and information security concerning clients, donation recipients and workers;
(3)conducting a management review to evaluate the bank's activities at least once a year;
(4)supervision including the conduct of periodic feedback and audits;
(5)validation of processes and procedures practised in the bank.

Suitability of a Unit for Freezing, Preservation and Use§

10.
(a)A private bank shall set out in its procedures the minimum requirements for the freezing and preservation of a unit in that bank, and shall in particular set a minimum number of nucleated cells in a umbilical cord blood unit intended for freezing and preservation, shall notify the Director of these procedures, and shall act in accordance with them.
(b)A private bank shall include information concerning the minimum requirements it has set as referred to in sub-regulation (a) in the consent form and in the information leaflet for the mother giving birth, alongside a statement of the minimum public requirements as in force at that time.

Supervision and Control§

11.
(a)The Director or a person authorised by the Director pursuant to these Regulations shall conduct an inspection before granting a permit to an applicant, and shall conduct periodic inspections and supervision activities, from time to time, of every private bank holding a permit, all in accordance with supervision and control procedures to be set by the Director.
(b)An applicant or a permit holder and the medical director of a private bank shall allow the Director, or a person authorised by the Director for this purpose, to conduct an inspection and to perform any action required for the purpose of examining the bank's and its employees' compliance with the professional instructions and adherence to the provisions of the law, the Regulations and the procedures in the private bank.

Page 1 of 2

Read the entire law on one page — continuous text, no page breaks, plus formal citations.

RegulationsHealthCriminal Law

תקנות דם טבורי (בנק דם טבורי פרטי), תשע"ב-2012

cord blood regulations

umbilical cord blood bank

private cord blood bank

dam tabori

UCB regulations

cord blood banking law

private umbilical cord blood

stem cell bank regulations

cord blood storage

neonatal blood banking